These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 30956191

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Triple negative breast cancer in people of North East India: critical insights gained at a regional cancer centre.
    Sharma M, Sharma JD, Sarma A, Ahmed S, Kataki AC, Saxena R, Sharma D.
    Asian Pac J Cancer Prev; 2014; 15(11):4507-11. PubMed ID: 24969877
    [Abstract] [Full Text] [Related]

  • 46. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.
    Zhu X, Ying J, Wang F, Wang J, Yang H.
    Breast Cancer Res Treat; 2014 Oct; 147(3):551-5. PubMed ID: 25234844
    [Abstract] [Full Text] [Related]

  • 47. Breast diseases: a histopathological analysis of 3279 cases at a tertiary care center in Pakistan.
    Siddiqui MS, Kayani N, Gill MS, Pervez S, Muzaffar S, Aziz SA, Setna Z, Israr M, Hasan SH.
    J Pak Med Assoc; 2003 Mar; 53(3):94-7. PubMed ID: 12779021
    [Abstract] [Full Text] [Related]

  • 48. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
    El Sharkawy SL, Farrag AR.
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
    [Abstract] [Full Text] [Related]

  • 49. Evaluation of HER2/neu oncoprotein in serum & tissue samples of women with breast cancer.
    Shukla S, Singh BK, Pathania OP, Jain M.
    Indian J Med Res; 2016 May; 143(Supplement):S52-S58. PubMed ID: 27748278
    [Abstract] [Full Text] [Related]

  • 50. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA, Mamoon N, Mushtaq S, Khadim MT.
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Ductal invasive mammary carcinoma--clinicopathological prognostic factors related to immunohistochemical expression of hormonal receptors and Her2/neu oncoprotein.
    Recăreanu F, Simionescu C, Georgescu CV, Pirici E.
    Rom J Morphol Embryol; 2011 Feb; 52(3 Suppl):1059-64. PubMed ID: 22119825
    [Abstract] [Full Text] [Related]

  • 54. A Comparative Study between FNAC and Histopathology in Diagnosis of Breast Lump.
    Islam A, Khondker NS, Rahman S, Reza E, Mahamud MM, Shaon SA, Mariam L, Pathan FH.
    Mymensingh Med J; 2015 Jul; 24(3):486-91. PubMed ID: 26329944
    [Abstract] [Full Text] [Related]

  • 55. Morphological profile and receptor status in breast carcinoma: an institutional study.
    Rao C, Shetty J, Kishan Prasad HL.
    J Cancer Res Ther; 2013 Jul; 9(1):44-9. PubMed ID: 23575073
    [Abstract] [Full Text] [Related]

  • 56. Frequency of breast cancer among Sudanese patients with breast palpable lumps.
    Ahmed HG, Ali AS, Almobarak AO.
    Indian J Cancer; 2010 Jul; 47(1):23-6. PubMed ID: 20071785
    [Abstract] [Full Text] [Related]

  • 57. [Comparision of HER2/neu oncogene detected by chromogenic in-situ hybridization and immunohistochemistry in breast cancer].
    Zhang GH, Shi DR, Liang XM, Hou JH, Kang SY, Zhu WD, Li XB, Shao Y, Chen LR, Zhou Y.
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):580-3. PubMed ID: 17134562
    [Abstract] [Full Text] [Related]

  • 58. Steroid hormone receptor association with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA, Mamoon N, Mushtaq S, Khadim MT, Jamal S.
    J Coll Physicians Surg Pak; 2010 Mar; 20(3):181-5. PubMed ID: 20392381
    [Abstract] [Full Text] [Related]

  • 59. Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions.
    Moriya T, Kanomata N, Kozuka Y, Fukumoto M, Iwachido N, Hata S, Takahashi Y, Miura H, Ishida K, Watanabe M.
    Breast Cancer; 2009 Mar; 16(3):173-8. PubMed ID: 19475479
    [Abstract] [Full Text] [Related]

  • 60. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
    Sasano H, Frost AR, Saitoh R, Matsunaga G, Nagura H, Krozowski ZS, Silverberg SG.
    Anticancer Res; 1997 Mar; 17(3C):2001-7. PubMed ID: 9216657
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.